• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无创性肝纤维化评估:当前和未来的临床与分子视角。

Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Itabashi-Ku, Tokyo 173-8610, Japan.

Division of Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

出版信息

Int J Mol Sci. 2020 Jul 11;21(14):4906. doi: 10.3390/ijms21144906.

DOI:10.3390/ijms21144906
PMID:32664553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7402287/
Abstract

Liver fibrosis is one of the risk factors for hepatocellular carcinoma (HCC) development. The staging of liver fibrosis can be evaluated only via a liver biopsy, which is an invasive procedure. Noninvasive methods for the diagnosis of liver fibrosis can be divided into morphological tests such as elastography and serum biochemical tests. Transient elastography is reported to have excellent performance in the diagnosis of liver fibrosis and has been accepted as a useful tool for the prediction of HCC development and other clinical outcomes. Two-dimensional shear wave elastography is a new technique and provides a real-time stiffness image. Serum fibrosis markers have been studied based on the mechanism of fibrogenesis and fibrolysis. In the healthy liver, homeostasis of the extracellular matrix is maintained directly by enzymes called matrix metalloproteinases (MMPs) and their specific inhibitors, tissue inhibitors of metalloproteinases (TIMPs). MMPs and TIMPs could be useful serum biomarkers for liver fibrosis and promising candidates for the treatment of liver fibrosis. Further studies are required to establish liver fibrosis-specific markers based on further clinical and molecular research. In this review, we summarize noninvasive fibrosis tests and molecular mechanism of liver fibrosis in current daily clinical practice.

摘要

肝纤维化是肝细胞癌(HCC)发展的风险因素之一。肝纤维化的分期只能通过肝活检来评估,而肝活检是一种有创的操作。用于诊断肝纤维化的非侵入性方法可分为形态学检查,如弹性成像和血清生化检查。瞬时弹性成像在肝纤维化的诊断中具有出色的性能,已被认为是预测 HCC 发展和其他临床结局的有用工具。二维剪切波弹性成像是一种新技术,可提供实时的硬度图像。基于纤维化和纤溶的机制,已经研究了血清纤维化标志物。在健康的肝脏中,细胞外基质的动态平衡由称为基质金属蛋白酶(MMPs)及其特定抑制剂,金属蛋白酶组织抑制剂(TIMPs)的酶直接维持。MMPs 和 TIMPs 可能是肝纤维化的有用血清生物标志物,也是肝纤维化治疗的有前途的候选者。需要进一步的研究来基于进一步的临床和分子研究建立基于肝纤维化的特异性标志物。在这篇综述中,我们总结了目前日常临床实践中的非侵入性纤维化检查和肝纤维化的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a7/7402287/1493d9c105fa/ijms-21-04906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a7/7402287/cbe759b38c09/ijms-21-04906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a7/7402287/1493d9c105fa/ijms-21-04906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a7/7402287/cbe759b38c09/ijms-21-04906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a7/7402287/1493d9c105fa/ijms-21-04906-g002.jpg

相似文献

1
Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives.无创性肝纤维化评估:当前和未来的临床与分子视角。
Int J Mol Sci. 2020 Jul 11;21(14):4906. doi: 10.3390/ijms21144906.
2
Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.瞬时弹性成像及其他非侵入性检测方法在病毒性肝炎患者肝纤维化评估中的应用
J Viral Hepat. 2009 May;16(5):300-14. doi: 10.1111/j.1365-2893.2009.01087.x. Epub 2009 Feb 25.
3
[The non-invasive diagnostic of fibrosis and cirrhosis of liver under chronic viral hepatitis: publications review].[慢性病毒性肝炎下肝纤维化和肝硬化的无创诊断:文献综述]
Klin Lab Diagn. 2016 Apr;61(4):209-14.
4
[Clinical Application of Non-invasive Diagnostic Tests for Liver Fibrosis].[肝纤维化非侵入性诊断测试的临床应用]
Korean J Gastroenterol. 2016 Jul 25;68(1):4-9. doi: 10.4166/kjg.2016.68.1.4.
5
Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.使用血清纤维化标志物、瞬时弹性成像(FibroScan)和实时组织弹性成像对肝纤维化进行无创评估。
Intervirology. 2008;51 Suppl 1:27-33. doi: 10.1159/000122602. Epub 2008 Jun 10.
6
Assessment of native liver fibrosis using ultrasound elastography and serological fibrosis indices in children with biliary atresia after the Kasai procedure.应用超声弹性成像和血清纤维化指标评估胆道闭锁患儿Kasai 术后的固有肝纤维化。
Acta Radiol. 2021 Aug;62(8):1088-1096. doi: 10.1177/0284185120948489. Epub 2020 Aug 18.
7
[Noninvasive estimation of fibrosis in chronic viral hepatitis].[慢性病毒性肝炎纤维化的无创评估]
Ugeskr Laeger. 2013 Aug 19;175(34):1877-82.
8
Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.用于肝脏疾病的超声剪切波弹性成像:对该领域众多参与者的批判性评估
Ultraschall Med. 2016 Feb;37(1):1-5. doi: 10.1055/s-0035-1567037. Epub 2016 Feb 12.
9
Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis.将非侵入性肝纤维化检测指标纳入临床实践:诊断与预后。
Clin Gastroenterol Hepatol. 2015 Nov;13(12):2190-204. doi: 10.1016/j.cgh.2015.07.030. Epub 2015 Jul 27.
10
Noninvasive ultrasound technique for assessment of liver fibrosis and cardiac function in Fontan-associated liver disease: diagnosis based on elastography and hepatic vein waveform type.基于超声弹性成像和肝静脉血流频谱类型的无创性超声技术评估 Fontan 相关肝病的肝纤维化和心功能。
J Med Ultrason (2001). 2021 Apr;48(2):235-244. doi: 10.1007/s10396-020-01078-8. Epub 2021 Jan 8.

引用本文的文献

1
Oncohepatology: Navigating liver injury in the era of modern cancer therapy.肿瘤肝脏病学:现代癌症治疗时代的肝脏损伤应对策略
World J Hepatol. 2025 Jun 27;17(6):106932. doi: 10.4254/wjh.v17.i6.106932.
2
A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy.一项随机临床研究,旨在评估硫酸锌对接受直接抗病毒治疗的慢性丙型肝炎患者可能的抗纤维化作用。
Inflammopharmacology. 2025 Jan;33(1):329-339. doi: 10.1007/s10787-024-01628-3. Epub 2025 Jan 9.
3
Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan.

本文引用的文献

1
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
2
Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi.新型乙型肝炎和肝细胞癌生物标志物:HBcrAg 和 M2BPGi 的临床意义。
Int J Mol Sci. 2020 Jan 31;21(3):949. doi: 10.3390/ijms21030949.
3
The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis.
日本东京肝病门诊患者的肌肉痉挛。
Medicina (Kaunas). 2023 Aug 22;59(9):1506. doi: 10.3390/medicina59091506.
4
Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media.在棕榈酸酯和果糖培养基中培养的原代大鼠肝细胞中,大麻二酚暴露后促纤维化反应的浓度依赖性减弱。
Cells. 2023 Sep 9;12(18):2243. doi: 10.3390/cells12182243.
5
The 3Rs in Experimental Liver Disease.实验性肝病中的3R原则
Animals (Basel). 2023 Jul 19;13(14):2357. doi: 10.3390/ani13142357.
6
Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy.消化系统恶性肿瘤的分子机制、诊断与治疗
Int J Mol Sci. 2023 Mar 30;24(7):6471. doi: 10.3390/ijms24076471.
7
- dual-modal magnetic resonance contrast-enhanced imaging for rat liver fibrosis stage.用于大鼠肝纤维化分期的双模态磁共振对比增强成像
RSC Adv. 2022 Dec 14;12(55):35809-35819. doi: 10.1039/d2ra05913d. eCollection 2022 Dec 12.
8
Extracellular vesicles as advanced therapeutics for the resolution of organ fibrosis: Current progress and future perspectives.细胞外囊泡作为治疗器官纤维化的先进疗法:当前进展和未来展望。
Front Immunol. 2022 Oct 20;13:1042983. doi: 10.3389/fimmu.2022.1042983. eCollection 2022.
9
IL-17A in Human Liver: Significant Source of Inflammation and Trigger of Liver Fibrosis Initiation.IL-17A 在人类肝脏中的作用:炎症的重要来源和肝纤维化起始的触发因素。
Int J Mol Sci. 2022 Aug 29;23(17):9773. doi: 10.3390/ijms23179773.
10
Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma.与饮酒和肝细胞癌相关的分子变化。
Int J Mol Sci. 2022 Aug 26;23(17):9679. doi: 10.3390/ijms23179679.
声辐射力脉冲弹性成像技术诊断非病毒性肝病肝纤维化的准确性:系统评价和荟萃分析。
PLoS One. 2020 Jan 15;15(1):e0227358. doi: 10.1371/journal.pone.0227358. eCollection 2020.
4
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.基质金属蛋白酶在肝癌上皮-间质转化中的作用。
Anal Cell Pathol (Amst). 2019 Nov 26;2019:9423907. doi: 10.1155/2019/9423907. eCollection 2019.
5
The oncoprotein HBXIP facilitates metastasis of hepatocellular carcinoma cells by activation of MMP15 expression.癌蛋白HBXIP通过激活MMP15表达促进肝癌细胞转移。
Cancer Manag Res. 2019 May 16;11:4529-4540. doi: 10.2147/CMAR.S198783. eCollection 2019.
6
Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis.肝细胞癌中上调的 MMP28 通过 Notch3 信号促进转移,并预测预后不良。
Int J Biol Sci. 2019 Feb 19;15(4):812-825. doi: 10.7150/ijbs.31335. eCollection 2019.
7
The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study.按年龄划分的 FIB4 指数截断值可提高非酒精性脂肪性肝病的诊断准确性:一项多中心研究。
J Gastroenterol. 2018 Nov;53(11):1216-1224. doi: 10.1007/s00535-018-1474-y. Epub 2018 May 9.
8
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.基质金属蛋白酶 11 基因多态性对肝细胞癌发生发展的影响。
Int J Med Sci. 2018 Apr 3;15(6):653-658. doi: 10.7150/ijms.23733. eCollection 2018.
9
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
10
Matrix Metalloproteinases (MMPs) in Liver Diseases.肝脏疾病中的基质金属蛋白酶(MMPs)
J Clin Exp Hepatol. 2017 Dec;7(4):367-372. doi: 10.1016/j.jceh.2017.09.004. Epub 2017 Oct 3.